Diagnostic Approach to Severe Reactive Hemophagocytic Lymphohistiocytosis
Researchers devised a comprehensive diagnostic approach to evaluating severe reactive hemophagocytic lymphohistiocytosis.
Diagnosis & Disease Information
Hemophagocytic Lymphohistiocytosis: Pretransplant Analyses May Prevent Unnecessary HSCT
In a large prospective study, investigators assessed whether pretransplant analyses could prevent unnecessary HSCT in children with HLH.
Emapalumab Appears to Be Safe and Efficacious in Primary Hemophagocytic Lymphohistiocytosis
Although emapalumab is an effective treatment for primary hemophagocytic lymphohistiocytosis (HLH), further research is needed for secondary forms of HLH.
Emapalumab Effective for Pediatric Primary Hemophagocytic Lymphohistiocytosis
Emapalumab as a target therapy may benefit children with primary HLH.
Outcomes With Hemophagocytic Lymphohistiocytosis in Pediatric Patients
Although pediatric patients with malignancy-associated HLH may have low mortality rates, they may subsequently die from underlying conditions from the malignant disease.
Hemophagocytic Lymphohistiocytosis Features in Primary Immunodeficiency
After defining mortality-related parameters in HLH, investigators noted that mortality rates were still high for patients with primary immunodeficiency.
Hemophagocytic Lymphohistiocytosis and Inflammatory Bowel Disease
Investigators aimed to characterize HLH in patients with moderate-to-severe inflammatory bowel disease.
Soluble Interleukin-2 Receptor Level in Adult Hemophagocytic Lymphohistiocytosis
The use of soluble interleukin-2 receptor level as a diagnostic test for secondary HLH in adults may be flawed.
- Loading...
Loading...
Next post in General Hematology
Loading... 
Loading...